ARS Pharmaceuticals Inc. (SPRY)
NASDAQ: SPRY
· Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.65
0.83%
After-hours: Aug 15, 2025, 07:32 PM EDT
ARS Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 15.72M | 7.97M | 86.58M | 2.07M | 500K | n/a | n/a | n/a | 10K | 20K | -1.32M | 189K | 464K | 663K | 754K | 528K | 2.11M | 2.11M |
Cost of Revenue | 4.98M | 1.09M | 865K | 112K | 18K | 11K | 12K | 21K | 7.31M | 6.55M | 3.65M | 317K | 4.35M | 5.42M | 430K | 541K | 492K | 466K |
Gross Profit | 10.73M | 6.88M | 85.72M | 1.96M | 500K | -11K | -12K | -21K | -7.3M | -6.53M | -4.97M | -128K | -3.89M | -4.76M | 324K | -13K | 1.62M | 1.65M |
Operating Income | -47.61M | -37.18M | 47.2M | -21.75M | -15.34M | -13.19M | -10.23M | -17.98M | -20.6M | -18.71M | -15.44M | -6.63M | -6.34M | -7.1M | -23.51M | -22.68M | -24.51M | -18.89M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 600K | 1.07M | n/a | n/a | 800K | n/a | n/a | n/a |
Pretax Income | -44.88M | -33.94M | 50.22M | -19.13M | -12.52M | -10.29M | -7.17M | -14.85M | -17.37M | -14.96M | -14.43M | -6.58M | -6.42M | -7.25M | -23.46M | -22.66M | -24.5M | -18.87M |
Net Income | -44.88M | -33.94M | 49.93M | -19.13M | -12.52M | -10.29M | -7.17M | -14.85M | -17.37M | -11.21M | -14.43M | -6.58M | -6.05M | -7.4M | -23.46M | -22.66M | -24.5M | -18.87M |
Selling & General & Admin | 54.31M | 41.1M | 35.49M | 19.28M | 8.94M | 7.96M | 6.82M | 14.98M | 13.3M | 12.18M | 10.73M | 2.93M | 2.46M | 2.34M | 7.39M | 6.7M | 6.48M | 6.37M |
Research & Development | 4.04M | 2.95M | 3.03M | 4.42M | 6.9M | 5.23M | 3.4M | 3M | 7.31M | 6.55M | 4.71M | 3.89M | 4.35M | 5.42M | 15.68M | 15.44M | 17.54M | 12.05M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.23M | 3.75M | 1.15M | 47K | -76K | -151K | n/a | n/a | n/a | n/a |
Operating Expenses | 58.35M | 44.06M | 38.52M | 23.7M | 15.84M | 13.19M | 10.23M | 17.98M | 20.61M | 18.73M | 15.44M | 6.82M | 6.81M | 7.76M | 23.08M | 22.14M | 24.02M | 18.42M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 218K | n/a | n/a | 151K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.59M | 5.68M | 5.54M | 5.43M |
Cost & Expenses | 63.33M | 45.15M | 39.38M | 23.82M | 15.84M | 13.19M | 10.23M | 17.98M | 20.61M | 18.73M | 15.44M | 6.82M | 6.81M | 7.76M | 23.51M | 22.68M | 24.51M | 18.89M |
Income Tax Expense | n/a | n/a | 288K | n/a | n/a | -32.28K | n/a | n/a | -20K | -3.75M | n/a | -20.08K | -369K | 151K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 98.36M | 98.06M | 97.95M | 97.03M | 96.83M | 96.49M | 96.13M | 95.58M | 94.91M | 94.23M | 94M | 93.77M | 93.77M | 93.77M | 35.04M | 35M | 34.88M | 34.77M |
Shares Outstanding (Diluted) | 98.36M | 98.06M | 97.95M | 97.03M | 96.83M | 96.49M | 96.13M | 95.58M | 94.91M | 94.23M | 94M | 93.77M | 93.77M | 93.77M | 35.04M | 35M | 34.88M | 34.77M |
EPS (Basic) | -0.46 | -0.35 | 0.51 | -0.2 | -0.13 | -0.11 | -0.07 | -0.16 | -0.18 | -0.12 | -0.15 | -0.07 | -0.06 | -0.08 | -0.67 | -0.65 | -0.7 | -0.54 |
EPS (Diluted) | -0.46 | -0.35 | 0.51 | -0.2 | -0.13 | -0.11 | -0.07 | -0.16 | -0.18 | -0.12 | -0.15 | -0.07 | -0.06 | -0.08 | -0.67 | -0.65 | -0.7 | -0.54 |
EBITDA | -44.6M | -35.5M | 47.2M | -21.75M | -15.32M | -13.18M | -10.21M | -17.96M | -20.6M | -18.71M | -15.14M | -6.62M | -6.34M | -7.05M | -23.03M | -22.11M | -24M | -18.4M |
EBIT | -44.88M | -37.18M | 47.2M | -21.75M | -15.34M | -13.19M | -10.23M | -17.98M | -20.6M | -18.71M | -15.44M | -6.63M | -6.34M | -7.1M | -23.46M | -22.66M | -24.5M | -18.87M |
Depreciation & Amortization | 279K | 1.68M | -29K | 21K | 18K | 11K | 12K | 21K | 20K | 20K | 299K | 317K | 488K | 456K | 430K | 541K | 492K | 466K |